Endo International (ENDP) – Credit Ratings
-
S&P Lowers Outlook on Endo Int'l (ENDP) to Negative; Ratings Affirmed
-
Endo's (ENDP) Ratings Cut to 'B1' by Moody's; Outlook is Negative
-
Endo Int'l (ENDP) Corp. Rating Affirmed by S&P Amid Par Pharma Deal
-
Endo (ENDP) Ratings Placed on Review for Downgrade by Moody's Following Par Pharma Announcement
-
Endo Luxembourg Finance I Placed on Review for Downgrade by Moody's (ENDP)
-
S&P Downgrades Endo Int\'l (ENDP) to 'B+'; Removes from CreditWatch Negative
-
Increase in Mesh Litigation Reserves is Credit Negative for Endo Int'l (ENDP) - Moody's
-
Endo Int'l (ENDP) Placed on CreditWatch Negative by S&P Following Auxilium (AUXL) Bid
-
S&P Lowers Outlook on Endo Int'l (ENDP) to Negative; Says Business is in Transition
-
Moody's Affirms Endo's (ENDP) CFR, Ba2-PD PoD; Changes Outlook to Negative
Back to ENDP Stock Lookup